Third Rock Ventures LLC is a leading venture capital firm based in Boston, MA, specializing in the life sciences sector. With a portfolio of 63 companies and 21 marketed products, they are dedicated to discovering, launching, building, and transforming innovative biotech and healthcare companies. Their recent highlights include the FDA approval of groundbreaking gene therapies for sickle cell disease and cerebral adrenoleukodystrophy, as well as the development of new treatments for cancer and mental health conditions.
Driven by their core values of doing the right thing and fostering diversity and inclusion, Third Rock Ventures is committed to making a positive impact in the life sciences industry. They are proud members of the Bioscience Investor Inclusion Group, a coalition focused on addressing diversity, equity, and inclusion. Through their investments and partnerships, Third Rock Ventures is at the forefront of advancing medical breakthroughs and improving patient outcomes.
Generated from the website
